Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

40 ta ish

Ish: Circulating tumor DNA as a predictive biomarker for colorectal cancer postsurgical recurrence: a systematic review and meta-analysis

  1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

    Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel +4

    MaqolaGlobal Cancer Incidence and ScreeningCA A Cancer Journal for Clinicians202160 iqtibos
    ABI

  2. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

    Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt +23

    Maqola202155 iqtibos
    ABI

  3. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

    Freddie Bray, Mathieu Laversanne, Hyuna Sung +4

    Maqola202419 iqtibos
    ABI

  4. Bias in meta-analysis detected by a simple, graphical test

    Matthias Egger, George Davey Smith, Martin Schneider +1

    Maqola199712 iqtibos
    ABI

  5. Measuring inconsistency in meta-analyses

    Julian P. T. Higgins, Simon G. Thompson, Jonathan J Deeks +1

    Sharh maqola200311 iqtibos
    ABI

  6. Meta-analysis in clinical trials

    Rebecca DerSimonian, Nan M. Laird

    Maqola19868 iqtibos
    ABI

  7. Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer

    Thomas Reinert, Tenna Vesterman Henriksen, Emil Christensen +35

    Maqola20194 iqtibos
    ABI

  8. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

    Jeanne Tie, Joshua D. Cohen, Yuxuan Wang +21

    Maqola20193 iqtibos
    ABI

  9. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

    Jeanne Tie, Yuxuan Wang, Cristian Tomasetti +23

    Maqola20163 iqtibos
    ABI

  10. Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA

    Nicholas P. Semenkovich, Jeffrey J. Szymanski, Noah Earland +3

    Sharh maqola20233 iqtibos
    ABI

  11. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

    Andreas Stang

    Maqola20102 iqtibos
    ABI

  12. Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging

    J. B. O'Connell, Melinda A. Maggard, Clifford Y. Ko

    Maqola20042 iqtibos
    ABI

  13. Liquid biopsy and minimal residual disease — latest advances and implications for cure

    Klaus Pantel, Catherine Alix‐Panabières

    Sharh maqola20192 iqtibos
    ABI

  14. Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)

    R Chin, Kevin Chen, Abul Usmani +6

    Sharh maqola20192 iqtibos
    ABI

  15. Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease

    Everett J. Moding, Barzin Y. Nabet, Ash A. Alizadeh +1

    Sharh maqola20212 iqtibos
    ABI

  16. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI